These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patterns of antiseizure medication utilization in the Human Epilepsy Project. Fox J; Barnard S; Agashe SH; Holmes MG; Gidal B; Klein P; Abou-Khalil BW; French J; Epilepsia; 2023 Dec; 64(12):3196-3204. PubMed ID: 37846772 [TBL] [Abstract][Full Text] [Related]
4. Pregabalin add-on for drug-resistant focal epilepsy. Panebianco M; Bresnahan R; Hemming K; Marson AG Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157 [TBL] [Abstract][Full Text] [Related]
5. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
6. Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021. Shankar R; Marston XL; Danielson V; Do Rego B; Lasagne R; Williams O; Groves L J Neurol; 2024 May; 271(5):2473-2483. PubMed ID: 38240828 [TBL] [Abstract][Full Text] [Related]
7. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study. Bolin K; Patric B; Tomson T Neurology; 2024 Jul; 103(2):e209500. PubMed ID: 38870473 [TBL] [Abstract][Full Text] [Related]
8. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA). Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633 [TBL] [Abstract][Full Text] [Related]
9. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252 [TBL] [Abstract][Full Text] [Related]
10. Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute? Janmohamed M; Lawn N; Spilsbury K; Chan J; Dunne J Epilepsia; 2021 Jan; 62(1):228-237. PubMed ID: 33236785 [TBL] [Abstract][Full Text] [Related]
11. Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations. Moloney PB; Costello DJ Seizure; 2021 Jan; 84():60-65. PubMed ID: 33285361 [TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813 [TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008 [TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878 [TBL] [Abstract][Full Text] [Related]
15. Anti-seizure medication prescription in epilepsy patients in South Korea: A seven-year population-based retrospective cohort study. Jang Y; Lee HS; Kim MS; Lee J; Jung KY Seizure; 2023 Jul; 109():70-76. PubMed ID: 37267669 [TBL] [Abstract][Full Text] [Related]
16. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Tudur Smith C; Weston J; Marson AG Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431 [TBL] [Abstract][Full Text] [Related]
17. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center. Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166 [TBL] [Abstract][Full Text] [Related]
18. Rational therapy with lamotrigine or levetiracetam: Which one to select? Asadi-Pooya AA; Farazdaghi M J Clin Neurosci; 2022 May; 99():49-52. PubMed ID: 35240475 [TBL] [Abstract][Full Text] [Related]